Riphah International University
Islamabad, Fedral, 44000, Pakistan
NCT Number: NCT05490784
To determine the effects of Lee Silverman Voice Treatment BIG on dynamic balance in Parkinson's patients
Looking for future studies?
Notify Me40 year–70 year
All sexes
Interventional
Not applicable
Islamabad, Fedral, 44000, Pakistan
This study will be conducted to compare the effects of Lee Silverman Voice Treatment BIG and conventional physiotherapy on dynamic balance in patients of PD. Patients will be recruited according to inclusion criteria and data will be collected from Riphah rehabilitation center, National Hospital Lahore. Dynamic gait index will be used as data collection tool to test dynamic balance of patients. Patients will be allocated to intervention groups by randomization. After approval from ethical committee, data collection will be started and informed consent will be taken from all patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients assigned to experimental group will get Lee Silverman Voice Treatment BIG along with conventional treatment.
patients in this group will get conventional treatment program encompassing set of exercises such as complex motor sequences, stretching, dual tasking, mental imagery and core stability.
Time frame: 9 months
Dynamic gait index assesses postural stability, gait, and balance. It evaluates various gait- related tasks with challenging situations such as head turn, speed change, obstacles and stairs climbing.
Riphah International University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06642454
Apathy, Basal Ganglia Diseases
Hefei, Anhui, China
View Trial DetailsNCT04581590
Basal Ganglia Diseases, Brain Diseases
João Pessoa, Paraíba, Brazil
View Trial DetailsNCT03608371
Basal Ganglia Diseases, Brain Diseases
Hallandale, Florida, United States
View Trial DetailsNCT05506813
Balance; Distorted, Basal Ganglia Diseases
Islamabad, Fedral, Pakistan
View Trial Details